Elderly patients with atrial f

Professor Wang Yutang in “ the ninth Forum on atrial fibrillation in China (CAFS 2011) ” meeting   talk as we all know, compared to patients with and without atrial fibrillation, atrial fibrillation significantly increased risk of stroke, in patients with thrombotic events, anticoagulation and antiplatelet therapy in atrial fibrillation patients will benefit patients. But elderly patients with atrial fibrillation in the elderly because of its tendencies both bleeding and thrombosis are unique, not only to increased risk of stroke, bleeding risk also increases, which gives the clinician a difficulty of anticoagulant therapy. And in the event of bleeding in elderly patients with atrial fibrillation, about one-third in patients with recurrent thrombotic events.on August 5, held at the Crowne Plaza Beijing new Yunnan “ the ninth Forum on atrial fibrillation in China (CAFS 2011) ” meeting, PLA, Professor of cardiovascular medicine Yutang Wang summarizes how the elderly patients with atrial fibrillation anticoagulation therapy experience editing medical Forum network to finish his speech to the essence content, share with readers.King Professor recommendations, on elderly room fibrillation patients of anticoagulant treatment required note following several points: 1, and joint China BK Frem and the anti-platelet drug than simple anti-platelet treatment may reduced death, and heart infarction and the then vascular of, composite end event; 2, and anticoagulant treatment in the to attention bleeding assessment, including balance thrombosis prevention, then made heart infarction or bracket thrombosis and the bleeding risk; 3, and bleeding of high risk factors including elderly, female, has past bleeding history, and renal function failure and the using had platelet sugar protein IIb/ IIIa receptor antagonists; 4, recommendations of elderly patients with atrial fibrillation anticoagulation international normalized ratio (INR) for 1.8-2.5 5, anticoagulant course rely on bleeding risk, bracket type and percutaneous coronary intervention (PCI).last, King Professor summary: 1, and age ≥75 aged of room fibrillation patients, if while has a item or a item above dangerous factors "hypertension, and heart failure, and diabetes, and stroke in the or short sexual brain deficiency blood attack (TIA)", should oral anticoagulant agent (OAC) anticoagulant treatment; 2, and both high thrombosis risk also has high bleeding risk of elderly room fibrillation patients, anticoagulant treatment in the should carefully weighed stroke and bleeding risk; 3, and high bleeding risk elderly room fibrillation patients in the, May using up than jiaqun alternative China method forest anticoagulant treatment, due to former has and China method forest also of anti-suppository effect, but cranial hemorrhage, bleeding risk reduced; 4, and elderly elderly room fibrillation PCI patients anticoagulant treatment to weighed stroke, and then made heart infarction, and bracket thrombosis and the bleeding risk, anticoagulant course rely on Yu bleeding risk, bracket type and the PCI situation; more related reading: ninth session China atrial fibrillation Forum held Sichuan University huaxi hospital Huang Dejia Professor do report (atrial fibrillation prevention of new viewpoint under Click to view the content of the essence of the report) Professor Wu Shulin of Guangdong provincial people's Hospital reports, of the persistent Atrial Fibrillation Ablation strategies Beijing Union Hospital of Professor Fang Quan reports on China and the atrial fibrillation anticoagulation in patients with the indications of and reflections on the strength of